Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study
|
|
- Rolf Darren Lyons
- 6 years ago
- Views:
Transcription
1 Redefining Sudden Cardiac Death: Insights from the Comprehensive UCSF SCD Study 8 September 2012 California Heart Rhythm Symposium Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine in Residence Cardiac Electrophysiology Section University of California, San Francisco
2 Disclosures Major Research grant: K12 RR (NIH) Research grant: R01 HL (NIH / NHLBI ) Minor Biotronik: Honorarium
3 Outline 1. What do we know (or think we know) about SCD 2. Gaps in SCD knowledge 3. Preliminary findings of Comprehensive UCSF SCD Study 4. Early study insights 5. Interesting case studies
4 Etiology of Sudden Cardiac Death Huikuri et al. N Engl J Med, Vol
5 Magnitude of Sudden Cardiac Death in the U.S. 500,000 # deaths/year 400, , , ,000 0 AIDS Breast Cancer Lung Cancer Stroke SCD 1 U.S. Census Bureau, Statistical Abstract of the United States: American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures Heart and Stroke Statistical Update, American Heart Association. 4 Circulation. 2001;104:
6 Sudden Cardiac Death: Definitions 2006 ACC/AHA/HRS standardized definition: SCA is the sudden cessation of cardiac activity so that the victim becomes unresponsive, with no normal breathing and no signs of circulation. If corrective measures are not taken rapidly, this condition progresses to sudden cardiac death. Cardiac arrest should be used to signify an event as described above, that is reversed, usually by CPR and/or defibrillation or cardioversion, or cardiac pacing. SCD should not be used to describe events that are not fatal.
7 Sudden Cardiac Death: Definitions VALIANT trial: Valsartan after acute MI and HF The cause of death was considered as SCD if death occurred suddenly and unexpectedly in a patient in otherwise stable condition, with no premonitory HF, MI, or another clear cause of death. These could have been witnessed deaths (with or without documentation of arrhythmias) or unwitnessed deaths if the patient had been seen within 24 hours before death. MERIT-HF trial: Metoprolol for Heart Failure SCD: Witnessed instantaneous death in the absence of progressive circulatory failure lasting for 60 min or more, unwitnessed death in the absence of pre-existence progressive circulatory failure or other causes of death
8 Sudden Cardiac Death: Definitions Criteria focus on the out-of-hospital occurrence of a presumed sudden pulseless condition and the absence of evidence of a noncardiac condition (e.g., central airway obstruction, intracranial hemorrhage, PE) as the cause of SCA. Adjudicated review of all available records (paramedic reports, rhythm strips, past medical records, etc.) World Health Organization (WHO) definition of SCD: Unexpected death within 1 h of symptom onset if witnessed Unexpected death within 24 h of having been observed alive and sx-free if unwitnessed
9 Methodological Issues in Population Studies of SCD Estimates in the US range from 184, ,000 annually due to subjective/ inconsistent methods of data collection Most data predates modern cardiac era Derived from homogenous (white) populations Where does the data come from? Death record review of listed COD Paramedic/ER narratives Which deaths can be counted as SCD? WHO criteria Documented VF Subjective interpretation of presentation narrative
10 Comprehensive Surveillance of SCD Oregon SUDS (Chugh, JACC, 2004) WHO criteria Portland, OR: population 1,000,000 Track dozens of ambulance companies and area hospitals Review of all available records SCA: 53/100,000
11 Sudden Arrhythmic Death vs. Sudden Cardiac Death The most relevant SD phenotype from an EP and public health standpoint (and the only one treated with ICD) is sudden arrhythmic death How many SCDs nationwide are caused by treatable arrhythmias? How do we know that presumed SCDs are even truly cardiac? Gold standard test is needed to rule out noncardiac and nonarrhythmic causes Pulmonary embolus Tamponade Aortic valve rupture
12 Comprehensive UCSF SCD Study By CA state law, all deaths occurring outside of the hospital (including ER deaths) have to be reported to the ME Office Nearly all sudden deaths are investigated ME Office is thus a robust surveillance method for all OOH SCDs Typical autopsy rates of prior case studies of SCD (from which paradigms have been derived): 10-15% The more likely a death is natural, the less likely autopsy is performed
13 Comprehensive Surveillance of SCD Oregon SUDS (Chugh, JACC, 2004) WHO criteria Portland, OR: population 1,000,000 Track dozens of ambulance companies and area hospitals Review of all available records SCA: 53/100,000 Autopsy rate: 11%
14 Comprehensive Surveillance of SCD in San Francisco All out of hospital and ER deaths are reported by law San Francisco Medical Examiner
15 Metropolitan San Francisco Population: ~750,000 residents (49 mi 2 ) ~1.5 million during business day Racially/ethnically diverse: 48% White 33% Asian-American 15% Hispanic 6.1% African-American By 2050, population of U.S. will closely reflect that of S.F. (US Census Bureau)
16 UCSF-ME SCD Study Design 3-year autopsy study of all sudden deaths in San Francisco (WHO criteria), including detailed cardiac evaluation: Heart weight/cmi LV septal thickness (origin of papillary muscles) Coronary vessels sectioned every 5mm to grade stenosis severity Trichrome histology to evaluate myocardial fibrosis All reported deaths reviewed every morning to screen for WHO criteria Cardiac, skin, and blood specimens for future studies (with NOK consent)
17 Study Eligibility Criteria Deaths reported to the MEO are preliminarily enrolled as SCDs if: 1. Age Death occurred within city and county of SF 3. Initial presentation meets WHO criteria Exclusion criteria: 1. Documented end-stage disease (e.g., ESRD on dialysis, metastatic cancer, COPD on home O2) 2. Current or very recent SNF/hospice care 3. Specific and significant recent-onset complaints 4. Significant evidence of suicide or overdose at time of presentation
18 Study Workflow Enrollment Autopsy PMH Record Review Adjudication Eligibility criteria are applied between each step as PMH and post-mortem data are collected
19 Case Adjudication Each case is determined to be arrhythmic, nonarrhythmic, or non-cardiac based on: - Past medical history (active problems, prescriptions, recent visits) - Medications (e.g., QT-prolonging, methadone) - Narratives and rhythm at death presentation - Autopsy findings (including toxicology and histology) Adjudication panel 2 Electrophysiologists Cardiac pathologist Medical Examiner Neurologist
20 Surveillance of WHO SCDs (2/1/2011-9/3/2012) Natural Deaths (Possible SCD) Non-Case, SCD SCD-Missed (External Only) SCD (Full Autopsy) SCD-Excluded Non-Arrhythmic Arrhythmic Non-Cardiac
21 Sudden Arrhythmic Deaths vs. Control (Trauma) Deaths SF ME Deaths N=1420 WHO SCDs Accidental Trauma deaths N=376 Autopsy Autopsy Arrhythmic Cardiac Non- Cardiac Non-arrhythmic Comparison to an appropriate control group, randomly sampled from the same population at risk for SCD, already receiving autopsy Steinhaus DA.Tseng ZH. Am Heart J Jan;163(1):
22 Study Cohort Demographics (2/2/11 8/15/12) * *
23 Relative SCD Incidence by Demographic Group (2/2/11 12/23/11) 3.2-fold higher incidence of arrhythmic SCD in males vs. females 1.6-fold higher incidence of arrhythmic SCD in black vs. white
24 SCD Rates in San Francisco, Rates of SCD per 100, SF 2007 WHO SCD SF 2007 SAD Chugh et al. (2004) de Vreede- Swagemakers et al. (1997) Low Rate Becker et al. (1993) High Rate Becker et al. (1993) 1. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J. Current burden of sudden cardiac death: mul\ple source surveillance versus retrospec\ve death cer\ficate- based review in a large U.S. community. J Am Coll Cardiol. 2004;44(6): de Vreede- Swagemakers JJ, Gorgels AP, Dubois- Arbouw WI, van Ree JW, et al. Out- of- hospital cardiac arrest in the 1990s " a popula\on- based study in the Maastricht area on incidence, characteris\cs and survival. J Am Coll Cardiol 1997;30(6): Becker, LB, Smith DW, Rhodes KV. Incidence of cardiac arrest: a neglected factor in evalua\ng survival rates. Ann Emerg Med 1993;22(1): Steinhaus DA.Tseng ZH. Am Heart J Jan;163(1):
25 Adjudicated Causes of WHO SCDs 33% of All 57% of WHO SCD Arrhythmic SCD (n=127) (n=74)
26 Nearly half of WHO SCDs are Non-Cardiac 47 of 127 (40%) WHO SCDs were non-cardiac
27 Presenting Rhythms for Witnessed SCDs
28
29
30
31
32 Morbidity Prevalence: Arrhythmic SCD vs. Trauma Deaths
33 Cardiac Parameters in Arrhythmic SCDs vs. Trauma Deaths Cardiac mass predicts arrhythmic SCD Higher degree of CAD in arrhythmic SCD LAD (46%) and RCA (35%) most commonly affected vessels Higher incidence of previous MI (23%) for arrhythmic SCD 12 (41%) of arrhythmic SCDs had microscopic replacement fibrosis without a grossly visible scar
34 Interstitial Fibrosis in SADs vs. Trauma Controls 40x LV septum, trichrome stain 75 yo AM trauma victim, minimal CAD 77 yo AM SAD victim, minimal CAD Global interstitial fibrosis score 1.5-fold higher in SADs than controls, adjusted for age, sex, ethnicity, CAD level
35 Sudden Cardiac Death in Patients with HIV Infection 2860 consecutive patients in a public HIV clinic (SFGH) April August deaths over 3.7 median years follow-up 13% SCDs, 86% (30/35) of all cardiac deaths Mean HIV+ SCD rate was 4.5-fold higher than background HIV- SCD rate
36 Magnitude of Sudden Cardiac Death in the U.S. 500,000 >2-fold overestimate # deaths/year 400, , , ,000 0 AIDS Breast Cancer Lung Cancer Stroke SCD 1 U.S. Census Bureau, Statistical Abstract of the United States: American Cancer Society, Inc., Surveillance Research, Cancer Facts and Figures Heart and Stroke Statistical Update, American Heart Association. 4 Circulation. 2001;104:
37 Etiology of Sudden Cardiac Death 2-fold overestimate Adapted from Huikuri et al. N Engl J Med, Vol
38 Early Insights WHO SCD criteria have a low PPV (60%) for SAD Men, blacks have 2-fold higher incidence of SAD than reference Active coronary lesion and CAD as the cause of SAD is far lower than previous estimates Interstitial myocardial fibrosis is associated with SAD and may serve a useful risk stratifier High rates of SCD in HIV: risk factors? Sudden neurologic death Vast underestimation of device/lead failures
39 Interesting Case Studies 78 yo Caucasian man Nonischemic dilated cardiomyopathy, stable EF 25% Paroxysmal AF Primary prevention ICD implanted 3 years ago, no shocks In usual state of health when wife left for shopping 3 hours later wife found him unresponsive Paramedics called, asystole on arrival, no resuscitation attempted
40 ICD Interrogation x 30
41 Interesting Case Studies At autopsy Massive subarachnoid hemorrhage (requires perfusing rhythm) Heart 760 g Neurocardiogenic injury VF due to acute adrenergic surge Despite rhythm documentation of VF, cause of death was neurologic
42 Interesting Case Studies 74 yo Filipino man 4 V CABG 2002 EF 22%, fixed defect anterior, inferior walls Diabetes Admitted for fever and bronchitis, receiving IV antibiotics Troponin negative, slightly fluid overloaded Called to consult on several asymptomatic runs of NSVT (5-7 beats) and to consider primary prevention ICD
43 Interesting Case Studies Recommended uptitration of ß blocker, ICD implant as an outpatient after completing antibiotic treatment ICD scheduled for 1 month after discharge 2 weeks later patient found dead in the morning by wife Pt had returned to usual state of health, no complaints the night before
44 Interesting Case Studies Referring MD At autopsy, 2.5 L fresh blood in stomach and duodenum Heart: no acute coronary lesions Cause of death: exsanguination ICD would not have prevented SCD, pt may not have survived procedure
45 Acknowledgements SF Medical Examiner s Office Ellen Moffatt Amy Hart UCSF Pathology Phil Ursell UCSF EP Section Jeff Olgin Brian Moyers Ben Colburn Lauren McGuire Dean Whiteman UCSF Epidemiology Eric Vittinghoff UCSF Neurology Anthony Kim SFFD/ SFGH Emergency Medicine Karl Sporer Clement Yeh UCSF Program in Human Genetics Brad Aouizerat Massachusetts General Hospital Dan Steinhaus
46
Sudden Cardiac Death: Definitions
Contemporary Epidemiology of Sudden Death: Insights from the Comprehensive UCSF SCD Study 23 October 2010 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor of
More informationRole of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death
Role of Non-Implantable Defibrillators in the Management of Patients at High Risk for Sudden Cardiac Death 29 October 2011 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Associate
More informationSupplementary Online Content
Supplementary Online Content Tseng ZH, Hayward RM, Clark NM, et al. Sudden death in patients with cardiac implantable electronic devices. JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2641.
More informationSudden Cardiac Death and Asians Disclosures
Sudden Cardiac Death and Asians Disclosures 7 February 2009 Asian Heart and Vascular Symposium None Zian H. Tseng, M.D., M.A.S. Assistant Professor of Medicine Cardiac Electrophysiology Section University
More informationRisk Stratification of Sudden Cardiac Death
Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of
More informationSudden Cardiac Death
Sudden Cardiac Death management challenges of a global problem Zayd A. Eldadah, MD, PhD Co-Director, Cardiac Electrophysiology, Washington Hospital Center Director, Cardiac Electrophysiology, Georgetown
More informationSudden Cardiac Death What an electrophysiologist thinks a cardiologist should know
Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden
More informationCardiac, Physiologic, and Real World Effects of Taser Use
Cardiac, Physiologic, and Real World Effects of Taser Use 1 June 2017 Conducted Energy Device Meeting San Francisco Police Department Zian H. Tseng, M.D., M.A.S. Murray Davis Endowed Professor Associate
More informationEpidemiologic Methods in the Study of Sudden Cardiac Death
Epidemiologic Methods in the Study of Sudden Cardiac Death Clinical Epidemiology and Biostatistics Mahidol University Bangkok Ross J. Simpson Jr, MD, PhD Division of Cardiology University of North Carolina
More informationHanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist
Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist Introduction. Basic Life Support (BLS). Advanced Cardiac Life Support (ACLS). Cardiovascular diseases (CVDs) are the number one cause of death
More informationSummary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
More informationZoll Medical--LifeVest:
Zoll Medical--LifeVest: Territory Manager: Sunny Brown Cell: (818) 916-6520 Objectives Why the LifeVest device exist Review indications for Wearable Cardioverter Defibrillator (WCD) use Give a brief description
More informationOut-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry
European Heart Journal (2003) 24, 1204 1209 Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Anton P.M. Gorgels*, Claudia Gijsbers, Jacqueline de
More informationWhere Does the Wearable Cardioverter Defibrillator (WCD) Fit In?
Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor of Medicine Director,
More informationVentricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center
Ventricular tachycardia and ischemia Martin Jan Schalij Department of Cardiology Leiden University Medical Center Disclosure: Research grants from: Boston Scientific Medtronic Biotronik Sudden Cardiac
More informationDEGREE (if applicable)
BIOGRAPHICAL SKETCH NAME: Chugh, Sumeet S., MD, FAHA, FHRS, FACC era COMMONS USER NAME (credential, e.g., agency login): chughs OMB No. 0925-0001/0002 (Rev. 08/12 Approved Through 8/31/2015) POSITION TITLE:
More informationVentricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC
Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of
More informationVest Prevention of Early Sudden Death Trial (VEST)
ACC Late Breaking Clinical Trials 2018 Vest Prevention of Early Sudden Death Trial (VEST) Jeffrey Olgin, MD, FACC Division of Cardiology, UCSF On behalf of the VEST Investigators Disclosures ClinicalTrials.gov
More informationSudden Cardiac Death in Korea : Epidemiology and Risk Factors
Sudden Cardiac Death in Korea : Epidemiology and Risk Factors Seok-Min Kang, MD, Ph D. Director, Heart Failure & Cardiac Wellness Center, Professor, Division of Cardiology, Severance Cardiovascular Hospital,
More informationSudden death as co-morbidity in patients following vascular intervention
Sudden death as co-morbidity in patients following vascular intervention Impact of ICD therapy Seah Nisam Director, Medical Science, Guidant Corporation Advanced Angioplasty Meeting (BCIS) London, 16 Jan,
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationICD. Guidelines and Critical Review of Trials. Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011
ICD Guidelines and Critical Review of Trials Win K. Shen, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Arizona Torino 2011 Disclosure Relevant Financial Relationship(s) None Off
More informationOut-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival
1500 JACC Vol. 30, No. 6 SUDDEN DEATH Out-of-Hospital Cardiac Arrest in the 1990s: A Population-Based Study in the Maastricht Area on Incidence, Characteristics and Survival JACQUELINE J. M. DE VREEDE-SWAGEMAKERS,
More informationVest Prevention of Early Sudden Death Trial (VEST)
ACC Late Breaking Clinical Trials 2018 Vest Prevention of Early Sudden Death Trial (VEST) Jeffrey Olgin, MD, FACC Division of Cardiology, UCSF On behalf of the VEST Investigators Disclosures ClinicalTrials.gov
More informationNoninvasive Predictors of Sudden Cardiac Death
2011 년순환기관련학회춘계통합학술대회 Noninvasive Predictors of Sudden Cardiac Death 영남대학교의과대학순환기내과학교실신동구 Diseases associated with SCD Previous SCD event Prior episode of ventricular tachyarrhythmia Previous myocardial
More informationCardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
More informationThe implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease
The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology
More informationCardiac MRI: Cardiomyopathy
Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD I do not have any relevant financial relationships with any commercial interests Cardiac MRI: Cardiomyopathy Laura E. Heyneman, MD Duke University Medical
More informationSecondary prevention of sudden cardiac death
Secondary prevention of sudden cardiac death Balbir Singh, MD, DM; Lakshmi N. Kottu, MBBS, Dip Card, PGPCard Department of Cardiology, Medanta Medcity Hospital, Gurgaon, India Abstract All randomised secondary
More informationPrimary prevention of SCD with the ICD in Nonischemic Cardiomyopathy
Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: Consulting and Clinical Trials Medtronic
More informationSudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC
Sudden Cardiac Death in Heart Failure: What do we need to know in 2018? Juan M. Aranda, Jr. MD FACC Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida Disclosures
More informationSudden Cardiac Arrest
Sudden Cardiac Arrest Amit Sharma, MD, FACP, FACC Interventional Cardiologist Rockledge Regional Medical Center Assistant Professor of Medicine University of Central Florida Disclosures No relevant financial
More informationICD Guidelines: who benefits from an ICD?
ICD Guidelines: who benefits from an ICD? Matthew Bennett Cardiac Electrophysiologist Vancouver Coastal Health, Device Lead Associate Professor, UBC Matthew.bennett@vch.ca Disclosures I have research collaborations
More informationHeart Rhythm Disorders. How do you quantify risk?
Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.
More informationTHE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA
THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA Speakers Bureau: Zoll / Lifecore, Sanofi Aventis, Cardionet Consultant: Boston Scientific, St. Jude Medical, Biotronik,
More informationICD Therapy. Disclaimers
ICD Therapy Rodney Horton, MD Texas Cardiac Arrhythmia Institute Texas Cardiovascular, PA Austin, TX Speaker s Bureau St. Jude Medical Medtronic Boston Scientific Disclaimers Clinical Advisory Panel St.
More informationSudden cardiac death: Primary and secondary prevention
Sudden cardiac death: Primary and secondary prevention By Kai Chi Chan Penultimate Year Medical Student St George s University of London at UNic Sheba Medical Centre Definition Sudden cardiac arrest (SCA)
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,
More informationHEART OF THE MATTER: cardiac issues in safe endoscopy & sedation
HEART OF THE MATTER: cardiac issues in safe endoscopy & sedation YUVAL KONSTANTINO M.D. CARDIOLOGY DEPARTMENT, ELECTROPHYSIOLOGY UNIT, SOROKA MEDICAL CENTER, BEN-GURION UNIVERSITY OUTLINE 1 2 3 Anticoagulation
More informationOut-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD
Out-Of-Hospital Management and Outcomes of Sudden Cardiac Death Abdelouahab BELLOU, MD, PhD Professor of Internal Medicine, Emergency Medicine, Therapeutics. Past President of the European Society for
More informationOverview and Latest Research on Out of Hospital Cardiac Arrest
L MODULE 1 Overview and Latest Research on Out of Hospital Cardiac Arrest Jamie Jollis, MD Co PI RACE CARS 2 Out of Hospital Cardiac Arrest in U.S. 236 000 to 325 000 people in the United States each year
More informationPreventing Sudden Death Current & Future Role of ICD Therapy
Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical
More informationΠρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:
Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια: Νεώτερα δεδομένα στη διαστρωμάτωση κινδύνου Εμμ. Μ. Κανουπάκης MD, PhD, FESC Πανεπιστημιακό Νοσοκομείο Ηρακλείου NIDCM Presence of LV dilatation
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationRational use of imaging for viability evaluation
EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium
More informationTachycardia Devices Indications and Basic Trouble Shooting
Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and
More informationAbbreviation List: 2017 by the American Heart Association, Inc. and the American College of Cardiology Foundation. 1
2017 AHA/ACC/HRS Systematic Review for the Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Data Supplement Table of Contents Part 1. For Asymptomatic
More informationTROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?
TROPONIN POSITIVE WHAT DOES IT MEAN? Frequently Asked Questions Regarding the Use of Troponin in the Clinical Setting What does an elevated troponin level mean? Elevated troponin is a sensitive and specific
More informationHeart Failure Overview. Dr Chris K Y Wong
Heart Failure Overview Dr Chris K Y Wong Heart Failure: A Growing, Global Health Issue Heart Failure 23 Million Afflicted Global Impact Worldwide ~23 million peopleworldwide afflicted with CHF 1 Exceeds
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationWhat Every Physician Should Know:
What Every Physician Should Know: The Canadian Heart Rhythm Society estimates that, in Canada, sudden cardiac death (SCD) is responsible for about 40,000 deaths annually; more than AIDS, breast cancer
More informationJournal of the American College of Cardiology Vol. 47, No. 6, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 47, No. 6, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.045
More informationPrevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias
Prevention of sudden cardiac death: With an emphasis on sudden cardiac death from ventricular arrhythmias The Toronto ACS Summit Toronto, March 1, 2014 Andrew C.T. Ha, MD, MSc, FRCPC Cardiac Electrophysiology
More informationSudden Cardiac Death in Sports: Causes and Current Screening Recommendations
Sports Cardiology Sudden Cardiac Death in Sports: Causes and Current Screening Recommendations Domenico Corrado, MD, PhD Inherited Arrhytmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and
More informationAsymptomatic Atrial Fibrillation: Detection and Management. 18 December nd Annual Advances in Heart Disease Palace Hotel, San Francisco
Asymptomatic Atrial Fibrillation: Detection and Management 18 December 2015 32 nd Annual Advances in Heart Disease Palace Hotel, San Francisco Zian H. Tseng, M.D., M.A.S. Associate Professor of Medicine
More informationAblation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation
Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation 25 October 2008 Update in Electrocardiography and Arrhythmias Zian H. Tseng, M.D., M.A.S. Assistant Professor
More informationDo All Patients With An ICD Indication Need A BiV Pacing Device?
Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology
More informationRADIATION HEART DISEASE: MANAGEMENT STRATEGIES
RADIATION HEART DISEASE: MANAGEMENT STRATEGIES AMMAR CHAUDHARY MBChB, ABIM, FRCPC ASSOCIATE CONSULTANT CARDIOLOGIST KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER - JEDDAH Scope of the Problem ~ 50
More informationBarry J. Maron, MD Hypertrophic Cardiomyopathy Institute Tufts Medical Center Boston, MA. Disclosures: Medtronic (Grantee) GeneDx (Consultant)
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality Shaped by 50 Years of Clinical Research and Practice Barry J. Maron, MD Hypertrophic Cardiomyopathy Institute
More informationHF and CRT: CRT-P versus CRT-D
HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA
More informationManaging Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology
Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation
More informationArrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh
Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention
More informationEVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington
EVALUATION OF THE 12 ATHLETE Karen Stout, MD Professor, Medicine and Pediatrics University of Washington NO DISCLOSURES OUTLINE Why evaluate athletes? What s the problem? What evaluation should be done?
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationRisk of sudden cardiac death. Original Article
Risk of sudden cardiac death Roxana Sadeghi (1), Nadia Adnani (2), Mohammad-Reza Sohrabi (3), Saeed Alipour Parsa (1) Abstract Original Article BACKGROUND: The aim of this study was to determine characteristics
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationArrhythmias (II) Ventricular Arrhythmias. Disclosures
Arrhythmias (II) Ventricular Arrhythmias Amy Leigh Miller, MD, PhD Cardiovascular Electrophysiology, Brigham & Women s Hospital Disclosures None Rhythms and Mortality Implantable loop recorder post-mi
More informationUpdate on Sudden Cardiac Death and Resuscitation
Update on Sudden Cardiac Death and Resuscitation Ashish R. Panchal, MD, PhD Medical Director Center for Emergency Medical Services Assistant Professor Clinical Department of Emergency Medicine The Ohio
More informationSports Cardiology: Matters of the Heart. AMSSM Exchange Lecture AOSSM 2013 Annual Meeting
Sports Cardiology: Matters of the Heart AMSSM Exchange Lecture AOSSM 2013 Annual Meeting Matthew Gammons, MD Vermont Orthopaedic Clinic Killington Medical Clinic Although sudden cardiac death is a relatively
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationArthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.
Saving Lives and Preventing Heart Failure: The MADIT Family of Trials Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Update in Electrocardiography
More informationTakotsubo cardiomyopathy. Joseph L. Blackshear, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Florida
Takotsubo cardiomyopathy Joseph L. Blackshear, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Florida 79 year old woman, pre chemo echo for esophageal cancer Post chemo, dehydration,
More informationJSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE»
JSC «Astana Medical University» PhD THESIS ANNOTATION Specialty: 6D110100 «MEDICINE» Title: «Prognostic efficiency of sudden cardiac death s predictors in preserved and moderately reduced left ventricle
More informationEthnic Differences in Sudden Cardiac Arrest. Joanna Ghobrial. A Thesis submitted in partial fulfillment of the requirements for the degree of
Ethnic Differences in Sudden Cardiac Arrest Joanna Ghobrial A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University of Washington 2014 Committee: Susan
More informationAll under the division of cardiovascular medicine University of Minnesota
The Team 1) Demetris Yannopoulos M.D. Medical Director, 2) Kim Harkins, Program Manager 3) Lucinda Klann, CARES Data Manager 4) Esther Almeida, Administrative Assistant All under the division of cardiovascular
More informationRecurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:
More informationOut-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland
Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.
More informationSudden Death in Athletes: What is the role of ECG Screening?
Sudden Death in Athletes: What is the role of ECG Screening? Byron K. Lee MD Professor of Medicine Director of EP Laboratory leeb@medicine.ucsf.edu Division of Cardiology Cardiac Electrophysiology Arrhythmias,
More informationArrhythmias Focused Review. Who Needs An ICD?
Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes
More informationArrhythmia in Acute Coronary Syndrome. E. Pruvot, MD, CHUV
Arrhythmia in Acute Coronary Syndrome E. Pruvot, MD, CHUV Background 10-15% of survivors of acute myocardial infarction (AMI) with LVEF die within the first 2 y after the event 1,2 80% of death are cardiac
More informationWho does not need a primary preventive ICD?
Who does not need a primary preventive ICD? Hildegard Tanner, Bern Universitätsklinik für Kardiologie Disclosure of potential conflicts of interest Travel grants for educational purposes from: Biosense
More information2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC
2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline Top Ten Messages Eleftherios M Kallergis, MD, PhD, FESC Cadiology Department - Heraklion University Hospital No actual or potential
More informationHIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD
HIP ATTACK Trial: Can we improve outcomes after a hip fracture with accelerated surgery? PJ Devereaux, MD, PhD Disclosure Member of research group with policy of not accepting honorariums or other payments
More informationThe 2014 Mayo Approach to the Management of HCM and Non-Compaction
The 2014 Mayo Approach to the Management of HCM and Non-Compaction R A Nishimura MD MACC MACP Judd and Mary Morris Leighton Professor Mayo Clinic No disclosures or conflict of interest CP1288794-1 Let
More informationWhat is the op3mal electrical therapy for refractory ventricular fibrilla3on?
Jon Jui MD, MPH What is the op3mal electrical therapy for refractory ventricular fibrilla3on? Strategies High performance + vasopressors CPR Effect Op:mize coronary blood flow An:-arrhythmics Defibrilla:on
More informationUpdate on Sudden Cardiac Death and Resuscitation
Update on Sudden Cardiac Death and Resuscitation Ashish R. Panchal, MD, PhD Medical Director Center for Emergency Medical Services Assistant Professor Clinical Department of Emergency Medicine The Ohio
More informationHealth Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010
Health Services Utilization and Medical Costs Among Medicare Atrial Fibrillation Patients / September 2010 AF Stat is sponsored by sanofi-aventis, U.S. LLC, which provided funding for this report. Avalere
More informationEnd of Life Care in IJN Our journey. Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia
End of Life Care in IJN Our journey Dato Dr. David Chew Soon Ping Consultant Cardiologist National Heart Institute Malaysia End of Life Dying is final part of everyone journey in life Deaths used to occur
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationSynopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist
Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal
More informationHot Topics in Cardiac Arrest. Should the patient go To the Cath Lab?
Hot Topics in Cardiac Arrest Should the patient go To the Cath Lab? Tim Russert 1950-2008 Host of NBC s Meet the Press Sudden Cardiac Arrest : Autopsy showed plaque rupture in his LAD ( per LA Times,
More informationAssessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis
Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis Investigator: Keiko Saito, MD Mentor: Yuji Saito, MD, PhD, FACP, FACC Department
More informationImplantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
More informationAtrial fibrillation (AF) is a disorder seen
This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,
More information1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI).
1) Severe, crushing substernal chest pain 2) radiate to the neck, jaw, epigastrium, or left arm. 3- rapid and weak pulse 4- nausea (posterior MI). 5- cardiogenic shock (massive MIs >40% of the left ventricle)
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationInappropriate electrical shocks: Tackling the beast
ESC Paris 2011 Inappropriate electrical shocks: Tackling the beast Gerhard Hindricks University of Leipzig Heart Center Dept. of Electrophysiology ESC Paris 2011 Inappropriate electrical shocks: Tackling
More information3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN
WS # 3 ICD Registry Case Scenarios with Structural Abnormalities Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss specific coding instructions
More informationSudden cardiac arrest How can we improve results of resuscitation?
Sudden cardiac arrest How can we improve results of resuscitation? 127 Applied Cardiopulmonary Pathophysiology 16: 127-132, 2012 Sudden cardiac arrest How can we improve results of resuscitation? Hein
More information